Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).
Country |
Year |
Number tested |
% infected (1) |
Study design (2) |
Setting/comments (3) (4) (5) |
Ref. |
|---|---|---|---|---|---|---|
Belgium |
2002-2003 |
549 |
(0.0-5.6) |
DT; SR |
DTC, LTS; serum |
1, 2a, 2 b, 8 |
Czech Republic |
2003 |
2320 |
0.1-0.7/ (0.0) |
DT; SR |
DTC, NSP, LTS, STI, OHC, HTC, IDUnk. opiate substitution centres; serum, saliva |
1b, 5, 7 |
Denmark |
1996-97 |
608 |
(0.0-3.4) |
SP |
PRI, DTC, serum |
1a, 1b, 1c, 2 |
Germany |
2000-01 |
2255 |
2.8-4.0 |
DT; SR |
DTC, ODD |
1, 3, 17 |
Estonia |
2001-02 |
4228 |
6.2-13.0 / (41) |
DT |
DTC, NSP, PHL, GPs, STI, OHC, ANT, HTC; serum |
1, 2 |
Greece |
2003 |
2031 |
0.2-0.8 / (0.0-1.2) |
DT |
DTC, LTS, OHC, PHL; serum |
1, 2, 9 |
Spain |
2002-2003 |
1815 |
9.7-21.3 / (33.0) |
DT |
DTC, HTC, STI; serum (IDUs starting detoxification treatment) |
25, 26, 28 |
France |
2002-2003 |
1022 |
(13.7-23.0) |
SR; SP (UAT) |
NSP, DTC, LTS, STR, GPs, residential centres; 25 cities, IDUnk |
4a, 4b, 16, 17 |
Ireland |
1998-99 |
682 |
3.5 -5.8 |
SP; SP (UAT) |
PRI; saliva, IDUnk |
2, 4, 8, 3 |
Italy |
2003 |
70484 |
14.2 / (0.99-37.5) |
DT |
DTC; serum, saliva; IDUnk (since 2004 prisons included) |
1a, 1b |
Latvia |
2003 |
1285 |
6.6-9.7 / (22.0) |
DT; SP |
DTC, OHC, NSP, STR, HTC; serum |
4, 5, 6, 7 |
Lithuania |
2003-2004 |
1571 |
2.4 / (0.0-0.4) |
DT; SP |
DTC, NSP, OHC; serum |
1, 3 |
Luxembourg |
2003 |
221 |
4.5 |
SR |
DTC, LTS, OHC, ARR, PRI |
1c |
Hungary |
2003 |
464 |
0.0 / (0.0) |
DT; SP |
DTC, PHL, STR; serum, saliva |
1, 2 |
Netherlands |
1998-2002 |
1595 |
(0.5-25.9) |
SP |
DTC, NSP, LTS, STR, methadone service; saliva and serum |
1, 3, 4, 6, 8, 9, 21 |
Austria |
2003 |
422 |
6.8 / (2.5-4.0) |
DT |
ODD, DTC, LTS, NSP; serum |
1, 1a, 2, 3, 4 |
Poland |
2002 |
2791 |
6.7-(29.7) |
DT; SP |
PHL, HTC, DTC, STI, STR; serum |
1a, 2 |
Portugal |
2003 |
8176 |
15.0-16.0 |
DT |
DTC; IDUnk |
10a |
Slovenia |
2003 |
1188 |
0.0 / (0.0) |
DT; SP (UAT) |
DTC, NSP; saliva |
1, 2 |
Slovakia |
2003 |
1044 |
0 |
DT |
DTC; serum |
4, 3 |
Finland |
2003 |
732 |
(0.0-0.4) |
DT |
NSP; serum |
6 |
Sweden |
1997 |
196 |
2.6 |
SP |
PRI, 9 sites; saliva |
1 |
United Kingdom |
2003 |
8433 |
(0.3-2.9) |
DT; SP (UAT) |
DTC, NSP, LTS, primary care and outreach, named HIV tests; saliva and serum |
5, 20 |
Bulgaria |
2003 |
992 |
(0.0) |
DT |
DTC, NSP, LTS, HTC; serum |
1a |
Romania |
2001 |
2135 |
(0.0) |
|
Public Health Departments |
1 |
Norway |
2004 |
264 |
(0.4) |
SP |
NSP, STR; serum |
2a, 2b |
Notes: This summary table intends to give a global overview of HIV prevalence in IDUs in the EU. In this table data are reported for the most recent year available. Data sources for more than one year are used if they improve generalisability (e.g. national data, out-of-treatment data). Prevalence in this table should not be compared with previous versions to follow changes over time, as inclusion of sources may vary according to data availability. For time trends see Tables INF 8-10 in the annex of this statistical bulletin. (1) The figures given in brackets show local estimates (or range of estimates) within the country. (2) Self-reported test results are less reliable than biological test results. (3) Having health problems is one selection criterion for admission to drug treatment in some countries or cities (Greece, Portugal, Rome), due to long waiting lists or special programmes for infected IDUs, and this may result in upward bias of prevalence. Prevalence from treatment data should therefore be interpreted in combination with non-treatment data. On the other hand, data from Italy and Portugal include non-IDUs and may thus underestimate prevalence in IDUs. (4) IDUnk = IDU not known, prevalence may be too low. (5) ODD = overdose deaths; DEM = drug emergencies; DTC = drug treatment centres; NSP = needle exchanges; LTS = low-threshold services; PHL = public health laboratories; STI = STI clinics; ANT = antenatal clinics; OHC = other hospital or clinics; PRI = prisons; ARR = arrests; GPs = general practitioners; HTC = HIV testing centres; STR = street; OTH = other. Sources: See [Table INF-8] | ||||||